1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Efficacy and safety of rituximab treatment in early primary Sjogren's syndrome … – 7thSpace Interactive (press release)

October 30, 2013Monoclonal Anti-CD20 Antibodiesadmin

Efficacy and safety of rituximab treatment in early primary Sjogren's syndrome ...
7thSpace Interactive (press release)
IntroductionPrimary Sjogren's syndrome (pSS) is an autoimmune disorder affecting exocrine glands and characterized, in most cases, by a rather mild clinical picture. However, a subgroup of pSS patients experience systemic extra-glandular involvement ...

Post navigation

← India Breast Cancer Surge Hinders Private Exams for Women – Bloomberg Matthew Ouimet meets his organ donor's mom – San Jose Mercury News →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos